The efficacy and safety of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for ovarian cancer: a systematic review and meta-analysis

BACKGROUND: The purpose of this study was to explore the efficacy and tolerability of poly ADP-ribose polymerase (PARP) inhibitors in patients with ovarian cancer. METHODS: The meta-analysis searched the PubMed, Web of Science, EBSCO, and Cochrane libraries from inception to February 2020 to identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yingzhu, Du, Nannan, Xie, Laidi, Jiang, Jing, Mo, Jiahang, Hong, Jiaze, Mao, Danyi, Ng, Derry Minyao, Shi, Huiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335450/
https://www.ncbi.nlm.nih.gov/pubmed/32622363
http://dx.doi.org/10.1186/s12957-020-01931-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335450/
https://www.ncbi.nlm.nih.gov/pubmed/32622363
http://dx.doi.org/10.1186/s12957-020-01931-7

Ejemplares similares